Mental Health First Aid, administered by the National Council for Behavioral Health, trains participants in mental health literacy, understanding risk factors and warning signs for mental health and addiction concerns and strategies for how to help someone in both crisis and non-crisis situations.
As highly accessible health care professionals, pharmacists have the opportunity to improve medication adherence and health outcomes of patients with bipolar disorder.
Building a rapport with your patients and supporting them is practically in the job description of a pharmacist. These abilities put pharmacists in a key position to intervene with people who may be contemplating suicide.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Although generic versions of prescription medications can be a cheaper alternative for patients, many perceive generics as less effective and less safe than their brand-name counterparts.
The prescription of stimulants for the treatment of attention deficit-hyperactivity disorder (ADHD) is increasing among adolescents and young adults, and a new study sheds light on possible safety concerns.
Suicide rates have risen in nearly every state since 1999.
In this clip, Taylor Watterson, a student at the University of Wisconsin-Madison School of Pharmacy, discusses the issue of pharmacists not recognizing when they are fatigued at work.
SSRIs have been shown to inhibit reuptake of serotonin in platelets, ultimately impairing platelet aggregation.
What landed this young man in critical condition, in the burn unit?
Once Spravato is determined as an appropriate treatment option, in accordance with the REMS, the patient will be treated at a certified treatment center that is trained to administer the medicine and address patient needs.
Flouxetine tablets were approved with the indication of treating multiple mental disorders.
The FDA has approved marketing of Lupin Pharmaceuticals’ Lurasidone Hydrochloride Tablets, a generic version of Sunovion Pharmaceuticals, Inc's lurasidone HCl (Latuda) tablets.
Top news of the day across the health care landscape.
How can pharmacists implement nonpharmacologic treatments for patients with dementia?
In this video, David Hager, PharmD, BCPS, the director of clinical pharmacy services at UW Health, Madison, WI, discusses the relationship between burnout and depression.
Stigma surrounding mental illnesses can prevent people from seeking treatment.
Majority of older patients with cancer and those who survived the disease found to have high levels of social and psychological wellbeing.
Public action to prevent suicide becomes crucial, as suicide rates rise in almost every state.
The results of a recent study show that persistent postnatal depression lasting 6 months or longer can have severe implications on child development.
Officials with the FDA are requiring safety label updates for fluoroquinolone antibiotics due to risks of mental health adverse effects, and blood sugar disturbances.
Officials with the FDA are requiring safety label updates for fluoroquinolone antibiotics due to risks of mental health adverse effects and blood sugar disturbances, according to a press release
The updated labeling will strengthen warnings for mental health adverse effects and risks related to hypoglycemia.
New research suggests psychiatric diseases that affect a patient’s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.
Officials with the FDA have approved an Alkermes aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults, according to the company.
